February 9, 2026

Henry Schein, Inc. (HSIC) Stock Analysis: Evaluating Its Unique Position in the Medical Distribution Sector

Henry Schein, Inc. (NASDAQ: HSIC) stands as a formidable player in the healthcare sector, specifically within the medical distribution industry. With a robust market capitalization of $9.67 billion, the company..

Bio-Rad Laboratories, Inc. (BIO) Stock Analysis: Unpacking a 15% Potential Upside

Bio-Rad Laboratories, Inc. (NYSE: BIO), a key player in the healthcare sector, is drawing significant attention from investors with its promising 15.42% potential upside. Specializing in medical devices, Bio-Rad is..

TransMedics Group, Inc. (TMDX) Stock Analysis: A Healthcare Innovator with 6.77% Potential Upside

TransMedics Group, Inc. (TMDX) has been capturing the attention of investors with its pioneering approach in the medical devices sector, particularly in the field of organ transplant therapy. Operating out..

Nuvalent, Inc. (NUVL): Analyst Ratings Signal 36.79% Upside in Biotech Innovator

Nuvalent, Inc. (NASDAQ: NUVL), a clinical-stage biopharmaceutical company, stands out in the biotechnology sector with a market capitalization of $8.04 billion. Headquartered in Cambridge, Massachusetts, Nuvalent is making significant strides..

Lantheus Holdings, Inc. (LNTH) Stock Analysis: Unlocking a 28.62% Potential Upside for Investors

Lantheus Holdings, Inc. (NASDAQ: LNTH) stands as a formidable player in the healthcare sector, with a particular focus on the specialty and generic drug manufacturing industry. This Bedford, Massachusetts-based company..

Waystar Holding Corp. (WAY) Stock Analysis: A 90.80% Potential Upside Amid Robust Analyst Support

Waystar Holding Corp. (NASDAQ: WAY), a key player in the healthcare information services sector, is capturing the attention of investors with its promising growth potential and strong analyst support. Founded..

AptarGroup, Inc. (ATR) Stock Analysis: A 19% Upside Potential in the Healthcare Sector

AptarGroup, Inc. (NYSE: ATR), a leading player in the healthcare sector specializing in medical instruments and supplies, stands out as a compelling investment opportunity with a noteworthy 19.02% potential upside..

Smith & Nephew SNATS, Inc. (SNN) Stock Analysis: Evaluating a Potential 4.99% Upside in the Healthcare Sector

Smith & Nephew SNATS, Inc. (NYSE: SNN), a stalwart in the healthcare sector, particularly in the medical devices industry, is attracting attention from investors with an intriguing potential upside of..

United Therapeutics Corporation (UTHR) Stock Analysis: Exploring a 9.46% Potential Upside and Robust Growth Prospects

United Therapeutics Corporation (NASDAQ: UTHR), a leading player in the healthcare sector, specializes in addressing critical medical needs through innovative treatments for chronic and life-threatening diseases. As of its latest..

Legend Biotech Corporation (LEGN) Stock Analysis: A 275% Upside Potential Amid Strong Analyst Support

Legend Biotech Corporation (NASDAQ: LEGN) is a promising player in the biotechnology sector, focusing on innovative cell therapies for treating cancer. With a market capitalization of $3.16 billion, the company’s..

GSK plc (GSK) Stock Analysis: Navigating a 60.23 USD Peak Amidst Potential Downside Risk

GSK plc (NYSE: GSK), a formidable player in the healthcare sector, has been making waves with its robust portfolio of vaccines and specialty medicines. With a market capitalization of approximately..

Bruker Corporation (BRKR) Stock Analysis: Unveiling a 29.81% Potential Upside in the Medical Devices Sector

For investors seeking opportunities in the healthcare sector, Bruker Corporation (NASDAQ: BRKR) presents an intriguing prospect. With a market capitalization of $6.37 billion, this Massachusetts-based company is a notable player..

Guardant Health, Inc. (GH) Stock Analysis: Unveiling a 22.96% Potential Upside in Precision Oncology

Guardant Health, Inc. (NASDAQ: GH) has emerged as a significant player in the rapidly evolving field of precision oncology. By offering cutting-edge blood and tissue tests, Guardant Health aims to..

Grifols, S.A. (GRFS) Investor Outlook: Capturing a 19.61% Potential Upside Amid Growth and Innovation

Grifols, S.A. (GRFS), a renowned name in the healthcare sector, stands out as a key player in the Drug Manufacturers – General industry. With its headquarters in Barcelona, Spain, the..

Labcorp Holdings Inc. (LH) Stock Analysis: Potential Upside with Strong Buy Ratings

Investors looking to delve into the healthcare sector should take note of Labcorp Holdings Inc. (NYSE: LH), a leading player in the Diagnostics & Research industry. With a market capitalization..

Jazz Pharmaceuticals plc (JAZZ) Investor Outlook: Examining a 31% Potential Upside with Strong Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers a compelling investment opportunity with a market capitalization of $10.06 billion. Headquartered in Dublin, Ireland, Jazz specializes..

The Ensign Group, Inc. (ENSG) Stock Analysis: Evaluating a 11.43% Potential Upside

The Ensign Group, Inc. (ENSG), a key player in the healthcare sector, has recently captured the attention of investors with its impressive market cap of $11.49 billion and an enticing..

BioMarin Pharmaceutical Inc. (BMRN)

⚠️ No article content returned.

..

The Cooper Companies, Inc. (COO) Stock Analysis: Unveiling a 10.84% Potential Upside in the Healthcare Sector

The Cooper Companies, Inc. (NYSE: COO), a key player in the healthcare sector, stands out in the medical instruments and supplies industry with a market capitalization of $16.32 billion. Headquartered..

HealthEquity, Inc. (HQY) Stock Analysis: Exploring a 49.94% Potential Upside

HealthEquity, Inc. (NASDAQ: HQY) is an intriguing player in the Healthcare sector, specifically within the Health Information Services industry. With a market capitalization of $6.87 billion, the company operates a..

Search

Funds

February 9, 2026

Search

Funds

February 9, 2026

FTSE 100

Funds